@neurogod
FDA AI deployment: Innovation vs oversight in drug regulation
The US Food and Drugs Administration (FDA) has stated that it wants to accelerate the deployment of AI across its centres. FDA Commissioner Martin A. Makary has announced an aggressive timeline to scale use of AI by 30 June 2025 and is betting big on the technology to change drug approval processes for the US.
0 reply
0 recast
1 reaction